Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure
- 1 April 1981
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 70 (4), 825-832
- https://doi.org/10.1016/0002-9343(81)90539-8
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Correlation of Pharmacological Effects with Plasma Levels of Antihypertensive Drugs in ManAnnual Review of Pharmacology and Toxicology, 1979
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978
- Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade.Heart, 1978
- Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.Circulation, 1977
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.JCI Insight, 1976
- Augmented Sympathetic Neurotransmitter Activity in the Peripheral Vascular Bed of Patients with Congestive Heart Failure and Cardiac Norepinephrine DepletionCirculation, 1968
- Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failureAmerican Journal Of Medicine, 1965
- Augmentation of the Plasma Nor-Epinephrine Response to Exercise in Patients with Congestive Heart FailureNew England Journal of Medicine, 1962